Results 131 to 140 of about 10,060 (149)

Canakinumab

Reactions Weekly, 2018
  +4 more sources

Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohort

Rheumatology, 2021
Francesco Licciardi, Roberta Naddei, Fabrizio De Benedetti   +2 more
exaly  

The effect of canakinumab treatment on growth parameters in children with familial Mediterranean fever

Clinical Rheumatology, 2023
Semanur Ozdel, Esra Baglan, Elif Arslanoğlu-Aydın   +2 more
exaly  

Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients

Modern Rheumatology, 2020
Balahan Makay, Nesrin Gülez, Betül Sözeri   +2 more
exaly  

Top bar navigation

Frontiers in Pediatrics, 2021
Burcu Bozkaya Yücel, Hülya Nalcacıoğlu   +1 more
exaly  

Pharmacokinetic and pharmacodynamic properties of canakinumab in patients with gouty arthritis

Journal of Clinical Pharmacology, 2013
Gangadhar Sunkara, Gerhard Krammer, Dan Howard   +2 more
exaly  

Canakinumab

Reactions Weekly, 2023
openaire   +1 more source

Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis

Journal of Clinical Pharmacology, 2016
Gangadhar Sunkara
exaly  

Canakinumab for the treatment of adult-onset Still’s disease

Expert Review of Clinical Immunology, 2020
Paolo Sfriso, Andrea Doria, Paola Galozzi   +2 more
exaly  

Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody

Clinical Pharmacokinetics, 2012
Stacey Tannenbaum, Philip J Lowe, Hermann Gram   +2 more
exaly